Ergoteles’s Cross Country Healthcare CCRN Stock Holding History

Ergoteles’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,465	Closed	-$225K	–	1313
2022 Q4	$225K	Buy	+8,465	New	+$276K	0.01%	1025

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Ergoteles's CCRN Position: Q1 2023 in Review

Ergoteles sold out of Cross Country Healthcare (CCRN) in Q1 2023, closing a stake of 8,465 shares — an estimated $225K sold.

Ergoteles first reported a position in CCRN in Q4 2022 and held it in 1 quarter. The position peaked at $225K in Q4 2022. 201 funds tracked by Wall St. Rank hold CCRN as of Q1 2023.

Ergoteles reported no remaining Cross Country Healthcare position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 8,465 Cross Country Healthcare shares in Q1 2023, an estimated $225K.
Ergoteles first reported a position in Cross Country Healthcare in Q4 2022 and held it in 1 quarter.
Ergoteles's Cross Country Healthcare position peaked at $225K in Q4 2022.
201 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.